The frequencies and numbers of CD8 T cells specific for the tumor antigen CEA (CD44hiCD8+Db-CEA tetramer+) were greater in FOLFOX-treated mice than in controls (Figure 3E and Figure S2B). The gene discussed is CD8A; the disease is neoplasm.